Home            Contact us            FAQs
    
      Journal Home      |      Aim & Scope     |     Author(s) Information      |      Editorial Board      |      MSP Download Statistics

     Advance Journal of Food Science and Technology


Anti-hepatocarcinoma Effects of a Food Additive Chrysin Nanosuspension against Human HepG2 Cells

1Zhi-ping Wang, 2Qun Zhou, 3Hui-zhe Shi, 3Sheng Xiong and 3Yi-fei Wang
1School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, China
2Hubei Key Laboratory of Natural Medicinal Chemistry and Resource Evaluation, Tongji School of Pharmacy, Huazhong University of Science and Technology, Wuhan 430030, China
3Institute of Biological Medicine, Jinan University, Guangzhou 510632, China
Advance Journal of Food Science and Technology  2015  8:627-630
http://dx.doi.org/10.19026/ajfst.7.1619  |  © The Author(s) 2015
Received: October 10, ‎2014  |  Accepted: November ‎3, ‎2014  |  Published: March 15, 2015

Abstract

Hepatocarcinoma, a malignant cancer, threaten human life badly. It is a current issue to seek the effective natural remedy from plant to treat cancer due to the resistance of the advanced hepatocarcinoma to chemotherapy. Chrysin (Chr), a major symbol ingredient in Chinese Propolis, has a wide range of pharmacological properties and is considered to have anti-hepatocarcinoma effects. However its low oral bioavailability restricts its wide application. In this report, Chr-Nanosuspension (Chr-NS) composed of Chr and poloxamer 188 was prepared by high pressure homogenization technique. The in vitro anti-hepatocarcinoma effects of Chr-NS relative to efficacy of bulk Chr were evaluated. The particle size and zeta potential of Chr-NS were 291.1 nm and -28.7 mV, respectively. MTT assay showed that Chr-NS effectively inhibited the proliferation of HepG2 cells and the corresponding IC50 values of Chr-NS and bulk Chr were 1.55 and 3.76 μg/mL. These results suggest that the delivery of Chr-NS is a promising approach for treating tumors.

Keywords:

Antitumor activity, chrysin, cytotoxicity, food additive, HepG2 cells, nanosuspension,


References

  1. Brechbuhl, H.M., R. Kachadourian, E. Min, D. Chan and B.J. Day, 2012. Chrysin enhances doxorubicin-induced cytotoxicity in human lung epithelial cancer cell lines: The role of glutathione. Toxicol. Appl. Pharm., 258(1): 1-9.
    CrossRef    PMid:21856323 PMCid:PMC3257857    
  2. Deng, X.K., W. Yin, W.D. Li, F.Z. Yin, X.Y. Lu and X.C. Zhang, 2006. The anti-tumor effects of alkaloids from the seeds of Strychnos nux-vomica on HepG2 cells and its possible mechanism. J. Ethnopharmacol., 106: 179-186.
    CrossRef    PMid:16442763    
  3. Gao, L., G.Y. Liu, J.L. Ma, X.Q. Wang, L. Zhou, X. Li and F. Wang, 2013. Application of drug nanocrystal technologies on oral drug delivery of poorly soluble drugs. Pharm. Res., 30: 307-324.
    CrossRef    PMid:23073665    
  4. Hadaruga, D.I., N.G. Hadaruga, G.N. Bandur and H.D. Isengard, 2012. Water content of flavonoid/ cyclodextrin nanoparticles: Relationship with the structural descriptors of biologically active compounds. Food Chem., 132(4): 1651-1659.
    CrossRef    
  5. Liang, M., S.C. Li, B. Shen, J.P. Cai, C. Li, Z.Y. Wang, X.G. Li, J. Gao, H.Y. Huang, X.Y. Zhang and J.Y. Li, 2012. Anti-hepatocarcinoma effects of Aconitum coreanum polysaccharides. Carbohyd. Polym., 88: 973-976.
    CrossRef    
  6. Lin, C.C., C.S. Yu, J.S. Yang, C.C. Lu, J.H. Chang, J.P. Lin, C.L. Kuo and J.G. Chung, 2012. Chrysin, a natural and biologically active flavonoid, influences a murine leukemia model in vivo through enhancing populations of T- and B-cells, and promoting macrophage phagocytosis and NK cell cytotoxicity. In Vivo, 26(4): 665-670.
    PMid:22773581    
  7. Lirdprapamongkol, K., H. Sakurai, S. Abdelhamed, S. Yokoyama, T. Maruyama, S. Athikomkulchai, A. Viriyaroj, S. Awale, H. Yagita, S. Ruchirawat, J. Svasti and I. Saiki, 2013. A flavonoid chrysin suppresses hypoxic survival and metastatic growth of mouse breast cancer cells. Oncol. Rep., 30(5): 2357-2364.
    CrossRef    
  8. Liversidge, G.G. and K.C. Cundy, 1995. Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs. Int. J. Pharm., 125: 91-97.
    CrossRef    
  9. Mo-Nan, Z., H. Guang-Rong and J. Jia-Xin, 2012. Effects of chemical modification and molecular weight distribution on iron binding ability of phytate-removal soybean protein isolate hydrolysate. Adv. J. Food Sci. Technol., 4(2): 78-83.
  10. Monasterio, A., M.C. Urdaci, I.V. Pinchuk, N. Lopez-Moratalla and J.J. Martinez-Irujo, 2004. Flavonoids induce apoptosis in human leukemia U937 cells through caspase-and caspase-calpain-dependent pathways. Nutr. Cancer, 50: 90-100.
    CrossRef    PMid:15572302    
  11. Parkin, D.M., 2001. Global cancer statistics in the year 2000. Lancet Oncol., 2: 533-543.
    CrossRef    
  12. Samarghandian, S., J.T. Afshari and S. Davoodi, 2011. Chrysin reduces proliferation and induces apoptosis in the human prostate cancer cell line pc-3. Clinics, 66(6): 1073-1079.
    CrossRef    PMid:21808878 PMCid:PMC3129972    
  13. Shao, J.J., A.P. Zhang, W. Qin, L. Zheng, Y.F. Zhu and X. Chen, 2012. AMP-activated protein kinase (AMPK) activation is involved in chrysin-induced growth inhibition and apoptosis in cultured A549 lung cancer cells. Biochem. Bioph. Res. Co., 423(3): 448-453.
    CrossRef    PMid:22659738    
  14. Sun, X., X. Huo, T. Luo, M. Li, Y. Yin and Y. Jiang, 2011. The anti-cancer flavonoid chrysin induces the unfolded protein response in hepatoma cells. J. Cell. Mol. Med., 15(11): 2389-2398.
    CrossRef    PMid:21199322 PMCid:PMC3822950    
  15. Sun, L.P., A.L. Chen, H.C. Hung, Y.H. Chien, J.S. Huang, C.Y. Huang, Y.W. Chen and C.N. Chen, 2012. Chrysin: A histone deacetylase 8 inhibitor with anticancer activity and a suitable candidate for the standardization of Chinese propolis. J. Agr. Food Chem., 60(47): 11748-11758.
    CrossRef    PMid:23134323    
  16. Thomas, M.B. and A.X. Zhu, 2005. Hepatocellular carcinoma: The need for progress. J. Clin. Oncol., 23: 2892-2899.
    CrossRef    PMid:15860847     
  17. Walle, T., Y. Otake, U.K. Walle, J.A. Brubaker and P.V. Halushka, 2000. Low oral bioavailability of the flavonoid chrysin, an aromatase inhibitor. Clin. Pharmacol. Ther., 67(2): 151.
  18. Yang, B., J. Huang, T.X. Xiang, X.D. Yin, X.R. Luo, J.B. Huang, F.L. Luo, H.Y. Li, H.Z. Li and G.S. Ren, 2014. Chrysin inhibits metastatic potential of human triple-negative breast cancer cells by modulating matrix metalloproteinase-10, epithelial to mesenchymal transition and PI3K/Akt signaling pathway. J. Appl. Toxicol., 34(1): 105-112.
    CrossRef    PMid:24122885    
  19. Yu, X.M., T. Phan, P.N. Patel, R. Jaskula-Sztul and H. Chen, 2013. Chrysin activates notch1 signaling and suppresses tumor growth of anaplastic thyroid carcinoma In Vitro and In Vivo. Cancer, 119(4): 774-781.
    CrossRef    PMid:22991264 PMCid:PMC3528831    
  20. Zarebczan, B., M. Kunnimalaiyaan and H. Chen, 2012. The natural flavinoid, chrysin, in the treatment of medullary thyroid cancer. J. Surg. Res., 172(2): 196.
    CrossRef    
  21. Zhang, Q., X.H. Zhao and Z.J. Wang, 2008. Flavones and flavonols exert cytotoxic effects on a human oesophageal adenocarcinoma cell line (OE33) by causing G2/M arrest and inducing apoptosis. Food Chem. Toxicol., 46: 2042-2053.
    CrossRef    PMid:18331776    
  22. Zhang, Q., X.H. Zhao and Z.J. Wang, 2009. Cytotoxicity of flavones and flavonols to a human esophageal squamous cell carcinoma cell line (KYSE-510) by induction of G2/M arrest and apoptosis. Toxicol. In Vitro, 23: 797-807.
    CrossRef    PMid:19397994    
  23. Zhang, T., X. Chen, L. Qu, J. Wu, R. Cui and Y. Zhao, 2004. Chrysin and its phosphate ester inhibit cell proliferation and induce apoptosis in Hela cells. Bioorg. Med. Chem., 12: 6097-6105.
    CrossRef    PMid:15519155    
  24. Zhang, D.R., T.W. Tan, L. Gao, W. Zhao and P. Wang, 2007. Preparation of azithromycin nanosuspensions by high pressure homogenization and its physicochemical characteristics studies. Drug Dev. Ind. Pharm., 33: 569-575.
    CrossRef    PMid:17520449    
  25. Zou, X.Q., S.M. Peng, C.P. Hu, L.F. Tan, H.W. Deng and Y.J. Li, 2011. Furoxan nitric oxide donor coupled chrysin derivatives: Synthesis and vasculo- protection. Bioorg. Med. Chem. Lett., 21(4): 1222-1226.
    CrossRef    PMid:21256748    

Competing interests

The authors have no competing interests.

Open Access Policy

This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Copyright

The authors have no competing interests.

ISSN (Online):  2042-4876
ISSN (Print):   2042-4868
Submit Manuscript
   Information
   Sales & Services
Home   |  Contact us   |  About us   |  Privacy Policy
Copyright © 2024. MAXWELL Scientific Publication Corp., All rights reserved